Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
about
Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assayCurrent and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes MellitusNovel diabetes autoantibodies and prediction of type 1 diabetesImportance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans.Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesRituximab selectively suppresses specific islet antibodies.Rising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosisAntigen targets of type 1 diabetes autoimmunityGenetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.Novel detection of pancreatic and duodenal homeobox 1 autoantibodies (PAA) in human sera using luciferase immunoprecipitation systems (LIPS) assay.Novel autoantigens in type 1 diabetes.Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplants.Bringing the human pancreas into focus: new paradigms for the understanding of Type 1 diabetes.Islet Autoantibody Analysis: Radioimmunoassays.Zinc transporter-8 autoantibodies can replace IA-2 autoantibodies as a serological marker for juvenile onset type 1 diabetes in India.Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A*24 alleles at the onset of type 1 diabetes.Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus.T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes.Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes.On type 1 diabetes mellitus pathogenesis.Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes.Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetesRelationship between ZnT8Ab, theSLC30A8gene and disease progression in children with newly diagnosed type 1 diabetes
P2860
Q24600478-0F89667D-B754-4B3C-85CE-67582DF1D69AQ26796516-49E85828-573D-4835-B63A-9A324A64B554Q27016130-AB646143-3DAB-4F56-AEBC-360581C2E1A0Q33670746-47E8EF07-7467-46F1-9AB7-5CD82CD5A50AQ35123421-96E4B9AE-34D7-4776-8BCA-28472F563EE8Q35205878-33EAD7F6-6E50-4636-B46E-7D70EEE5A85CQ35207904-B71D8BED-05AA-4E63-9AB1-290C1CC72C8EQ35227218-9B828D94-A464-4233-9E16-D88C40FCAD06Q35766972-4A892022-0D8C-4B38-BECB-FDC8A76A671DQ35852999-ED5820A5-9AB2-4B0F-A338-85577A44F591Q36013572-D148BA68-BC6A-4B0C-92A9-280D6A4C19E7Q36092708-A0E8932E-22AA-4E5A-9ABE-AA58F8DC8E03Q36853493-52556AC5-7FC0-42DC-965B-2BA5D9F6A391Q36881807-326388EE-5644-4A6C-BF6C-D6ED8ED87EEBQ37316533-3D1B4A43-C613-49F5-A447-8FA7466B1C10Q38692421-D16755CB-D754-4C20-90B6-15FEF1D73612Q38932737-D8543FD3-C0E3-436B-BA61-708CF682D0C8Q40658448-DD60E77E-BED6-4746-89F3-811269CEF760Q40944599-4EDAAA4C-B5BF-4EF8-B9A8-5FFF51240213Q44044590-C0F5212E-3CAC-442A-BB40-8ABFFA7F714DQ46556379-DC6FC032-8584-4515-9363-29D38F53EF70Q47093542-CE8EF6C4-C5A4-42A7-A454-552530786DE7Q47763684-6AFA09B9-CD22-4F3F-BFB0-0D31A4A7EB57Q47824146-4B674BE4-7621-4735-B92F-0F6DD89C191BQ48256704-B5E28CE5-5B21-469D-8D81-4E92EC9094A6Q49189362-36069812-F012-4153-B765-59B974A3A91EQ50556599-46A6E814-2D63-4A2C-A2D1-B3CE8A745D96Q57365402-CD8B129E-590D-4771-88FC-B3F74970B6CCQ58201161-8952C402-B838-4246-A3E0-95BA8F7217B0
P2860
Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@ast
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@en
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@nl
type
label
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@ast
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@en
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@nl
prefLabel
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@ast
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@en
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@nl
P2093
P2860
P356
P1476
Kinetics of the post-onset dec ...... ype 1 diabetic human subjects.
@en
P2093
A-G Ziegler
G S Eisenbarth
H W Davidson
J C Hutton
J M Wenzlau
L M Frisch
T J Gardner
P2860
P304
P356
10.1210/JC.2010-0169
P407
P577
2010-07-07T00:00:00Z